In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
Rheumatoid arthritis isn’t just about joint pain—it can affect multiple organs, leading to complications like heart disease, lung fibrosis, eye conditions, skin vasculitis, and nervous system issues. Micah…
David Perlmutter, MD, interviews Georgia Ede, MD, to explore the groundbreaking relationship between metabolic health and psychiatric disorders. They discuss how lifestyle and dietary changes, including ketogenic diets,…
Hiva Kolodrubetz, NP, provides an engaging and detailed session on anti-diabetic medications, focusing on safe prescribing and effective management strategies. Highlighting pharmacological mechanisms, A1C goals, and patient-centered care,…
Portable ultrasound technology is revolutionizing rheumatology diagnostics and care. Muhammad Bardi, MD, highlights its role in detecting inflammatory arthritis, vasculitis, and lupus manifestations. These devices offer real-time imaging…
Gregory Nicholas explores the evolution of personalized healthcare, focusing on compound pharmacies as a solution to rising medication costs and complexity. By emphasizing quality, customization, and affordability, he…
Mark R. Barakat, MD, founder and director of research, Retina Macula Institute of Arizona, discusses an analysis of the Phase 2/3 PHOTON trial. Dr Barakat explained that pre-dose…
Brian Eble, MD, shares his journey into pediatric cardiology, emphasizing the profound impact of teamwork in saving children’s lives. Reflecting on advancements in treating sudden cardiac events, congenital…
Jimmy Ruiz, MD, reflects on his career journey in North Carolina and the transformative progress in lung cancer treatment. Early in his career, limited tools like chemotherapy presented…
David Simel, MD, and William Kim, MD, explore renal cell carcinoma in this JAMA Clinical Review podcast. They discuss key insights from the 2019 Nobel Prize research on…
Advances in non-small cell lung cancer (NSCLC) treatment have transformed care from a one-size-fits-all approach in the 1990s to highly personalized regimens today. Treatment now considers actionable mutations…
